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Catabolism of histamine in the isolated glomeruli and tubules of
the rat kidney
HANNA E. ABBOUD
Division of Nephrology, Department of Medicine, Case Western Reserve University and Veterans Administration
Medical Center, Cleveland, Ohio
Catabolism of histamine in the isolated glomeruli and tubules of the rat
kidney. Histamine alters renal hemodynamics including the glomerular
microcirculation, and histamine receptors are present in rat glomeruli.
We have recently shown that isolated rat glomeruli, but not cortical
tubules, incubated with the histamine substrate L-histidine synthesize
histamine. This study explores the catabolic pathways of histamine in
isolated glomeruli and cortical tubules of the rat kidney. Glomeruli and
cortical tubules were incubated with radiolabelled histamine, and the
products were separated on thin layer chromatography (TLC). Glomer-
uli predominantly catabolized histamine to acid metabolites of the
diamine oxidase (histaminase) pathway, imidazole acetic acid and
ribosylimidazole acetic acid, and to a lesser extent to the inactive
methylation product, Nr-methylhistamine (7.5% vs. 2.5%). Tubules on
the other hand catabolized histamine to Nr-methylhistamine and to a
lesser degree to acid metabolites (7.6% vs. 2.3%). The methyl donor S.
Adenosyl-methionine (SAM) (104M) markedly enhanced the produc-
tion of Nr-methylhistamine in both glomeruli and tubules ( + 600%)
but had no effect on the production of acid metabolites. In the presence
of equimolar concentrations of SAM, tubules continued to methylate
histamine to a greater extent than glomeruli (46.0% vs. 18%). In both
glomeruli and tubules, the diamine oxidase inhibitor, amino-guanidine,
abolished the production of acid metabolites while amodiaquine and
pyrilamine, inhibitors of the methylation pathway, markedly reduced
the production of NT-methylhistamine. In addition, in the presence of
SAM, tubules catabolized nonlabelled histamine to a greater extent
than glomeruli. These studies show that tubules have a greater capacity
than glomeruli to degrade histamine and that histamine is differentially
catabolized in these segments. A major pathway of histamine catabo-
lism in glomeruli results in the formation of biologically active products.
Catabolisme de l'histamine dans des glomerules et des tubules isolés de
rein de rat. L'histamine altère l'hemodynamique rénale notamment Ia
microcirculation glomerulaire, et des récepteurs de l'histamine sont
presents dans les glomerules de rat. Nous avons récemment montré que
des glomerules isolés de rat, mains non des tubules corticaux, incubés
avec de Ia L-histidine, Ic substrat de l'histamine, synthetisent de
l'histamine. Cette étude explore les voies cataboliques de l'histamine
dans des glomerules et des tubules corticaux isolCs de reins de rat. Les
glomerules et les tubules corticaux ont été incubés avec de l'histamine
radiomarquée, et les produits ont été séparés par chromatographie en
couche mince (TLC). Les glomerules catabolisaient preférentiellement
l'histamine en des métabolites acides de Ia voie de Ia diamine oxidase
(histaminase), l'acide imidazole acetique et l'acide ribosylimidazole
acetique, et a un moindre degre en produit de methylation inactif, le Nr-
mCthylhistamine. Les tubules, quant a eux, catabolisaient l'histamine
en Nr-mCthylhistamine et a un moindre degré en métabolites acides
(7.6% contre 2.3%). La S-Adénosyl-méthionine (SAM) (104M), un
donneur de methyle, a stimulé de facon marquee Ia production de Ni-
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methylhistamine dans les glomerules et les tubules ( + 600%) mais
n'avait pas d'effet sur La production des mCtabolites acides. En pres-
ence de concentrations équimolaires de SAM, les tubules continuaient
de méthyler l'histamine de facon plus importante que les glomerules
(46.0% contre 18%). Dans les glomerules comme dans les tubules, un
inhibiteur de La diamine oxidase, l'amino-guanidine, a supprime Ia
production de métabolites acides, alors que l'amodiaquine et Ia pyrila-
mine, des inhibiteurs de Ia voie de methylation, ont réduit considerable-
ment Ia production de Ni-méthylhistamine. En outre, en presence de
SAM, les tubules catabolisaient l'histamine non marquee de facon plus
importante que les glomerules. Ces etudes montrent que les tubules ont
une plus forte capacite que les glomerules a degrader l'histamine, et que
l'histamine est catabolisee de facon différente dans ces segments. Une
voie majeure du catabolisme de l'histamine dans les glomerules aboutit
a Ia formation de produits biologiquement actifs.
There is increasing evidence that the vasoactive amine hista-
mine may play an important role in modulating renal function
under physiological conditions or in the course of renal injury
[1—101. In this context, histamine has been shown to dilate the
renal circulation and to increase salt and water excretion [1—31,
to decrease the ultrafiltration coefficient [3], and to increase
renin release [41. In addition, studies utilizing the systemic
administration of antihistamines [5—8] strongly suggest a role
for histamine in mediating the renal injury in some [5, 6] but not
all [7, 8] forms of experimental glomerulonephritis. Very few
studies have examined the intrarenal metabolism of histamine
[9—Il]. Isolated rat glomeruli have a high activity of the specific
histidine decarboxylase [11]. We and others recently demon-
strated that isolated rat glomeruli, but not cortical tubules, are
capable of synthesizing histamine when incubated with the
substrate L-histidine [10] and that histamine acting via an Hz
receptor specifically alters glomerular cyclic nucleotide levels
[12, 13]. These observations suggest a biological role of the
amine in this nephron structure. The rates of synthesis and
catabolism of histamine are among the major factors that
influence the dynamics of histamine metabolism and availability
in tissues [14]. The catabolism of histamine proceeds via two
major enzymatic pathways [14—16]: (1) oxidative deamination
by histaminase (diamine oxidase) to imidazole acetic acid
(IMAA) which could be conjugated to form ribosyl imidazole
acetic acid; (2) methylation of the imidazole ring of histamine by
histamine methyl transferase to NT-methylhistamine (Ni-MH)
which may be subsequently oxidized to Ni-methylimidazole
acetic acid (Nr-MIAA). The ability of whole kidney tissue to
catabolize histamine in vitro and in vivo has been recognized
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for a long time [15, 161, However, the precise localization and
the contribution of each pathway to histamine catabolism
within the kidney are not known. It has recently become
evident that a variety of histamine metabolites, which were
formerly treated as inactive byproducts, possess significant
biologic activity [14, 17, 18]. Our studies were designed to
examine the catabolic pathways of histamine in glomeruli and a
mixed population of cortical tubules.
Methods
L-histamine[Ring-2-'4C] dihydrochloride 59.7 mCi/mmole,
and S-adenosyl-L-methionine-[14C-methyl] 57.9 mCi/mmole
were purchased from Amersham Corp., Arlington Heights,
Illinois. The '4C-labelled histamine was purified on cellulose
plates as described [19]. [(/3-side chain label)-3H] histamine was
prepared from [(/3-side chain label)-3H] L-histidine 10 Ci/mmole
(New England Nuclear Corp., Boston, Massachusetts) as de-
scribed previously [10]. Non-labelled S-Adenosylmethionine
was obtained from Boehringer, Manheim Biochemicals, India-
napolis, Indiana. Non-labelled histamine dihydrochioride, L-
histidine, imidazole acetic acid, and bovine serum albumin were
purchased from Sigma Chemical Co. (St. Louis, Missouri). 1-
Methyl-4-(2-aminoethyl) imidazole hydrochloride (Nr-methyl-
histamine) was purchased from Calbiochemical Corp. (San
Diego, California). Pyrilamine maleate was a product of K and
K Laboratories, Inc., (Plainview, New York). Aminoguanidine
sulphate was purchased from Eastman Organic Chemicals,
Eastman Laboratory and Speciality Chemicals, Eastman Ko-
dak Co., Rochester, New York. Amodiaquine was kindly
supplied by Dr. S. A. Fusari, Park, Davis and Co. (Detroit,
Michigan).
Isolation of glomeruli and tubules. Kidney tissue used for
preparation of glomeruli and tubules was obtained from male
Sprague-Dawley rats weighing 200 to 250 g, maintained on a
standard diet, (Purina Laboratory Rat Chow, Ralston Purina
Co., St. Louis, Missouri), and having free access to tap water.
Rats were anesthesized and the kidneys were perfused in situ
with 60 to 80 ml of modified Krebs Ringer Phosphate Buffer
(KRB) until surfaces were completely blanched. The kidneys
were then quickly excised, decapsulated and placed in an ice-
cold KRB. Glomeruli and tubules were prepared from renal
cortical tissue by a combination of sieving and differential
centrifugation as described in our previous reports [10, 13]. The
purity of each glomerular suspension (95 to 98%) was evaluated
by light microscopic examination and counting of glomeruli [10,
13]. Glomeruli or tubules were then resuspended in 0,1 M
sodium phosphate buffer containing 2.7 mivi KCI, 0.8 M CaC12,
and 0.1% glucose (incubation buffer) so that 8 to 12 mg of
glomeruli or tubules were contained in 100 1d.
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Freshly prepared glomeruli and tubules suspended in incuba-
tion buffer were distributed into 1.5 ml microcentrifuge tubes
(Eppendorf) kept on crushed ice at 0°C. Inhibitors, labelled
histamine, and the methyl donor S-Adenosylmethionine (SAM)
were added in that order when appropriate. The final incubation
volume was 200 pi. Tubes were mixed thoroughly and incubat-
ed for 120 mm, or as specified in Results, at 37°C in a metabolic,
shaking water-bath. In addition, the tubes were also shaken
manually over 30 mm during the incubation. In each experi-
ment, blank incubations were run using glomerular and tubular
suspensions which were heated in a boiling water bath for 10
mm before the addition of the various agents. At the end of the
incubation, the reaction was stopped by the addition of 10 d of
a solution containing amodiaquine and aminoguanidine (each in
a concentration of 2 2 x 104M); in addition, 10 d solution
containing cold histamine, imidazole acetic acid, and methylhis-
tamine, each in a concentration of 0.75 mg/ml, were added to all
tubes as a carrier and to facilitate the extraction and identifica-
tion of labelled histamine and metabolites. Tubes containing
glomerular and tubular suspensions were then frozen and stored
at —20°C.
Extraction of histamine and metabolites. The extraction
method of Code et al [20] was carried out in all the experiments
with radiolabelled histamine. In preliminary experiments, we
found that this extraction step is necessary for clear and
reproducible separation of histamine and its metabolites.
Glomerular and tubular suspensions in microcentrifuge tubes
were frozen and thawed in an ethanol/dry ice bath (four times)
to insure release of histamine and metabolites. A l0-d aliquot
was taken for the determination of total radioactivity. Tn-
chioroacetic acid (200 pi of 20% TCA) was then added to
precipitate the proteins. After 30 mm in the cold, proteins were
precipitated by centrifugation at x 12,800g for 30 mm in a
microcentnifuge (Eppendorf). The supernate was transferred to
clean tubes and the pellet was resuspended in 100 d of 20%
TCA and centrifuged again. The supernates were combined.
TCA was removed from the supernate by three extractions with
three volumes of water-saturated ether. The supernatant solu-
tion was then dried using a centrifugal vacuum evaporator
(Savant Instruments, Hicksville, New York). The dried materi-
al was taken up in 0.5 ml of acidified methanol and centrifuged;
the supernate was transferred to fresh tubes and evaporated
using the centrifugal vacuum evaporator. The dried residue was
dissolved in a 50-pd volume of absolute methanol to provide
about 1500 dpm/tl. A l0-d aliquot of the reconstituted absolute
methanol was counted to determine the recovery. Of the
radioactivity present in the original homogenate 76.0% 4.5
(sEM) was recovered in the final alcoholic extract. Aliquots of
the methanolic extracts measuring 10 1d were then applied to
1.0-cm regions on 20 X 20 cm silica gel chromatogram plastic
sheets without fluorescent markers (EM, E. Merck, Darmstadt,
Germany). The dried plates were activated for 60 mm at 110°C
prior to use. The chromatogram sheets were marked 1 inch
from the bottom and 1.0 cm from each side into 1-cm sample
application regions, each separated from one another by 1.5 cm.
The sheets were chromatographed in an ascending direction 16
cm in glass chromatogram chambers using methanol: chloro-
form: ammonium hydroxide 12:7:1 as solvents [21, 23]. Ten
microliters of a standard solution of histamine, imidazole acetic
acid, and methylhistamine (each in a concentration of 0.1
mg/ml) were also placed on each plate and co-chromato-
graphed. After drying the plates thoroughly, histamine and
methylhistamine were identified by spraying with ninhydrin and
imidazole acetic acid by spraying with sulphanilic acid reagent
[20, 23]. In this system, histamine and its major metabolites
were well separated and could be measured accurately. As soon
as the plates were developed and stained, the spots representing
histamine and its two major metabolites were outlined, and the
chromatographic strip was divided into 1- to 1.5-cm wide spots.
The areas representing each spot were cut by scissors and
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placed into separate vials. The radioactivity was estimated by
liquid scintillation measurement of radioactivity in a cut section
of the chromatogram suspended in 15 ml of scintillation fluid
(Aquasol, New England Nuclear Corp., Arlington Heights,
Illinois).
Studies with nonlabelled histamine. The catabolism of hista-
mine in glomeruli and tubules was also examined utilizing
nonlabelled histamine as substrate, and histamine levels were
then determined by radioenzymatic assay [241. The incubation
conditions were similar to those with labelled histamine with
minor modifications. The glomerular and tubular suspensions
were incubated with various concentrations of nonlabelled
histamine in the absence and in the presence of SAM. Control
tubes were incubated with boiled suspensions of glomeruli and
tubules. SAM was also added to the control tubes of the
incubations carried out in the presence of SAM. At the end of
the incubation, all tubes were immersed in boiling water for 10
mm to terminate the reaction and destroy SAM [24]. The tubes
were then frozen and stored at —20°C before histamine determi-
nation. For determination of histamine, the tubes were then
frozen and thawed three times and centrifuged at x 12,800g for
30 mm. The supernate was separated and adjusted to pH 7.9.
Proteins in the precipitate were assayed by the method of
Lowry et al [25]. Histamine was detemined at 50-pd aliquots of
the supernatants by a double isotope radioenzymatic assay [10,
24]. Samples containing high concentrations of histamine were
diluted with 0.1 M Na phosphate buffer pH 7,9 prior to assay.
Statistical Analysis. Differences between glomeruli and tu-
bules were analyzed using unpaired two-tailed Student's t test,
and paired one-tailed t test for changes within glomeruli or
tubules.
Results
Glomeruli and cortical tubules incubated under the same
conditions catabolized '4C-labelled histamine to major products
that could be separated on silica gel TLC. Figure 1 shows the
distribution of radioactivity in a representative experiment in
the absence and presence of methyl donor SAM. A '4C-peak
occurred at the position occupied by IMAA. This peak was
higher in glomeruli than in tubules, 7.45% vs. 2.40%, and was
little affected by the addition of SAM to the incubation, 7.60%
vs. 2.25% of total radioactivity, respectively. In this system
however, imidazole acetic acid riboside, the conjugated metab-
olite of IMAA, and Ni—methyl imidazole acetic acid, the
deaminated product of methylhistamine, cannot be separated
from IMAA [211. That Nr-MIAA does not contribute signifi-
cantly to the radioactivity in this peak is suggested by the
absence of change in counts over this spot both by the addition
of SAM, which enhances the radioactivity of Nr-MH spot by
several folds, and by the inclusion of specific methylation
inhibitors which abolish the production of Ni--MH. Further-
more, we observed no change in counts when incubations were
carried out in the presence of tranylcypramine, a monoaminoxi-
dase inhibitor (data not shown). This peak was therefore taken
as representative of the acidic metabolites of the diamine
oxidase pathway: imidazole acetic acid and ribosyl imidazole
acetic acid (IMAA + R). The identity of this peak as repre-
sentative of acid metabolites of the diamine oxidase pathway is
confirmed by the studies utilizing the specific diamine oxidase
inhibitor aminoguanidine (Table 1). Another '4C peak occurred
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Flg 1. TLC of '4C-histamine and its products in glomeruli (solid bars)
and tubules (hashed bars) incubated in the absence (upper panel) and
the presence (lower panel) of 104M S-Adenosylmethionine (SAM).
Note the difference in the scales. The positions of reference compounds
are indicated by the letters: A, IMAA + R (imidazole acetic acid and
ribosylamidazole acetic acid); B, H (histamine); C, N -MH (Ni—
methylhistamine). Values shown in this and in all subsequent experi-
ments are after subtracting the blank (incubation and TLC performed
under identical conditions but in the presence of boiled tissue). Incuba-
tions were carried out in the presence of 5 x 106M '4C-histamine for
120 mm. Total radioactivity recovered averaged 16,580 dpm. Protein
content in glomeruli averaged 485 g and in tubules 467 rg per
incubation sample.
at the position occupied by ring-methylated histamine (Ni--
MH). This peak was higher in tubules than in glomeruli both in
the absence and presence of SAM, 4.5% vs. 2.38% and 45.5%
vs. 18.2% of the total recovered radioactivity, respectively. The
identity of this product as that of the methylation pathway was
confirmed by the studies utilizing the methylation inhibitors
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Table 1. Effect of inhibitors on the catabolism of histamine in isolated glomeruli and tubulesa
Control
Amodiaquine Aminoguanidine
io- M 10 M io- M 10-6 M
Effect of amodiaquine and aminoguanidine
Glom 324.0" 46.0N'r-MH Tub 595.3 88.9
310.8 52.2 143.0 28.5
379.0 17.6 198.0c 55.8
339.8 20.8
468.6" 31.3
277.0 27.8
5497d 49.8
Glom 104.3 17.6IMAA + R Tub. 17.5" 7.6
86.5 12.2 89.9 21.4
16.4" 7.0 14.2d 6.4
ll.4 3.7
2.8c 1.0
4.l 2.4
4.1 33
Effect of pyrilamine
Glom 295,3 21.5N-MH Tub 562.0" 42.6
Pyrilamine
io M io
276.0 40.0 106.& 27.6
431.7 49.8 207.0c 50.9
Glom 73.3 22.3IMAA + R Tub 16.5" 5.8
70.3 11.9 65.5 4.7
23.4d 2.1 38.1 6.1
Abbreviations: N'r-MH, N'r-methylhistamine; IMAA + R, imidazole acetic acid and ribosyl imidazole acetic acid.
Incubations were carried out in the presence of 5 x 106M '4C-labelled histamine and 105M S-Adenosylmethionine for 120 mm. Labelled
histamine and metabolites were separated on TLC. For details, see Methods.
b Mean SEM of values from three experiments (each determined in duplicate or triplicate incubation samples); data are expressed as pmoles/mg
protein.
Significantly different from corresponding control levels (without inhibitors) at (P < 0.05 or higher degree of significance; paired t test).
"Levels in tubules significantly different from corresponding levels in glomeruli (P < 0.05 or higher degree of significance; unpaired t test).
(amodiaquine and pyrilamine) (Table 1). Another less promi-
nent peak of radioactivity migrated between histamine and NT-
methylhistamine. The pattern of radioactivity over this spot,
both in the presence and absence of SAM, resembled that
produced by Ni-methylhistamine in glomeruli and tubules but
was of a much lower magnitude. Although this peak probably
represents a methylation metabolite [211, we have not attempt-
ed further identification of this product. The percent counts
over all other remaining spots were less than 1% of the total
radioactivity.
Figure 2A and B shows that there was a progressive increase
in product formation for at least 150 mm of incubation in the
absence and presence of SAM. When the glomerular and
tubular protein concentration was progressively increased (Fig.
3A and B), there was a corresponding increase in the production
of both metabolites, up to at least 500 g tissue protein.
Subsequent incubations were therefore carried out in glomeru-
lar and tubular suspensions containing 300 to 500 g protein
(approximate wet weight of 6 to 12 mg) per incubation sample
for 120 mm.
The addition of increasing concentrations of SAM to the
incubation medium (Fig. 4) enhanced the production of Nr-
methylhistamine in both glomeruli and tubules but had no effect
on the production of (IMAA + R). The production of Nr-MH
by tubules continued to be much higher than that in glomeruli at
all tested concentrations of SAM.
Figure 5 shows the effect of varying the concentration of
radiolabelled histamine in the incubation medium on the pro-
duction of both products. There was a progressive increase in
the production of (IMAA + R) and NT-MH in both glomeruli
and tubules. At all concentrations of histamine tested, the
production of Nr-MH in tubules exceeded that in glomeruli
while the production of (IMAA + R) in glomeruli exceeded that
in tubules.
Figure 6 shows the data from four separate experiments
performed in the absence and presence of saturating concentra-
tions of SAM (l04M). Both in the absence and presence of the
methyl donor SAM, tubules catabolize histamine to methylhis-
tamine to a much greater extent than glomeruli. The addition of
SAM enhanced the methylation pathway by more than tenfold
in both glomeruli and tubules. However, glomeruli predomi-
nantly catabolized histamine to (IMAA + R) and the amount of
(IMAA + R) produced was not affected by the addition of
SAM. Tubules catabolized histamine to (IMAA + R) to a much
lesser degree. To eliminate the possibility that a higher uptake
of SAM or radiolabelled histamine by tubules as compared to
glomeruli was a cause of the differential catabolism of hista-
mine, glomeruli and tubules were permeabilized by repeated
freezing and thawing (three times) prior to the incubation with
radiolabelled histamine. Production of Nr-MH in tubules and
glomeruli after this procedure averaged 940.0 42.0 vs. 390.0
26.0, respectively (pmoles/mg protein; mean SEM of three
incubation samples).
Table 1 shows that 106M amodiaquine, an inhibitor of the
methylation pathway, [14, 15] inhibited the production of Nr-
MH in both glomeruli and tubules but had no effect on the
production of IMAA + R. Conversely, 107M and 106M amin-
oguanidine, a specific inhibitor of the diamine oxidase pathway,
[14, 15] abolished the production of IMAA + R but had no
effect on the production of NT-MH. Pyrilamine, an Hi receptor
antagonist, and a known inhibitor of the methylation pathway
[14], also inhibited the production of Nr-MH but had no effect
on the production of IMAA + R.
Finally, to verify the magnitude of histamine catabolism
observed in the TLC studies, experiments were carried out with
nonlabelled histamine, and histamine levels were determined by
radioenzymatic assay. The percent recovery of histamine (50%)
measured by the radioenzymatic assay in the samples incubated
with SAM was similar to that incubated without SAM and
confirms previous observations that SAM is totally destroyed
by boiling [24]. In the absence of added SAM, and at both
concentrations of exogenous histamine (0.5 x 106M and 5 x
Fig. 2. Time course of product formation in isolated glomeruli and
tubules. Incubations were carried out in the presence of 5 x l0M '4C-
histamine for 120 mm in the absence (A) and presence (B) of 104M S-
Adenosylmethionine (SAM). Labelled histamine and products were
separated on thin layer chromatography. Note the difference in the
scales. Each point represents the mean SEM of four determinations
(two incubation samples aliquoted in duplicates).
106M), there was a small decline in the levels of histamine in
glomeruli (% — 6.95 4.5 and —6.42 2.6) and in tubules(% — 8.78 4.5 and —7.13 1.9), respectively (Fig. 7). On
the other hand, in the presence of SAM, there was a marked
decline in the levels of histamine in both glomeruli and tubules.
Similar to the experiments with the labelled substrate, the
p. protein
Fig. 3. The effect of increasing glomerular and tubular protein concen-
trations on product formation. Glomeruli and tubules were incubated
with 5 x l06M '4C-histamine for 120 mm in the absence (A) or
presence (B) of l04M S-Adenosylmethionine (SAM). Labelled hista-
mine and metabolites were separated on thin layer chromatography.
Note the difference in the scales. Each point represents the mean SEM
offour determinations (two incubation samples aliquoted in duplicates).
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decline in histamine levels was greater in tubules than in
glomeruli at both low and high concentrations of histamine
added to the incubation (% — 30.54 2.7 and —9.5 2.9 in
glomeruli) vs. (% — 57.97 3.9 and 34.37 1.9 in tubules),
respectively.
Discussion
These studies demonstrate that cortical tubules have a much
higher capacity to degrade histamine than glomeruli and that
histamine is differentially catabolized in these two segments of
the rat renal cortex. In the absence of exogenous SAM,
glomeruli catabolize histamine predominantly via the diamine
oxidase pathway while tubules catabolize histamine via the
methylation pathway. The predominance of the methylation
pathway in tubules over that in glomeruli was observed both in
C
a)
0
C.
0)
E
a)
a)0
Ea
the absence and presence of saturating concentrations of SAM,
This observation suggests that the activity of histamine methyl-
transferase is higher in tubules than in glomeruli. That these
differences are not due to differential uptake of radiolabelled
histamine or SAM is also supported by the finding that prior
permeabilization of the tissue by repeated freezing and thawing
did not influence the pattern of distribution of methylation
products in either glomeruli or tubules. Although the endoge-
nous content of histamine in glomeruli is higher than that in
tubules (10], a change in specific activity of '4C-histamine
added to tissues also cannot explain the observed differences in
catabolism since the absolute amount of '4C-histamine added
exceeds by more than 30-fold the endogenous histamine con-
tents [10]. Furthermore, the studies with nonlabelled histamine
show that in the presence of SAM, the rate of decline of
histamine levels in tubules was much higher than in glomeruli
and thereby confirms the TLC studies.
The higher rate of histamine catabolism in tubules as corn
pared to glomeruli is consistent with the presence of a very
active histamine methyltransferase in whole rat kidney [22],
which consists predominantly of tubules. The striking, enhanc-
ing effect of the methyldonor SAM on the methylation pathway
in glorneruli and tubules suggests that its presence may also be a
major factor that determines histamine availability in the kid-
ney. A similar requirement of SAM for histamine methylation
by whole renal tissue in vitro was observed by other investiga-
tors [26, 27]. The concentration of SAM in whole renal tissue in
situ is high (=5 x lO5M) (28, 29] and, at this concentration of
SAM, tubules continue to methylate histamine to a much higher
extent than glomeruli. Although extrapolation from in vitro to in
vivo studies should be cautious, these experiments carried out
in the presence of exogenous SAM are likely to reflect the
catabolism of histamine in vivo. Since SAM is a highly unstable
compound [29], the amount of SAM remaining in glomeruli and
tubules after the isolation procedure is probably negligible and
C
0
a
C).
E
a)0
Ea
Fig. 5. Product formation by isolated glomeruli and tubules as a
function of increasing concentration of '4C-histamine. Incubations
were carried out with varying concentrations of '4C-labelled histamine
(by dilution with cold histamine) for 120 mm in the presence of 104M S-
Adenosylmethionine (SAM). Labelled histamine and products were
separated on thin layer chromatography. Each point represents the
mean SEM of four determinations (two incubation samples aliquoted
in duplicates).
does not reflect in situ levels. It is conceivable that the higher
levels of histamine in glomeruli than in tubules that we have
observed in our previous studies [10] are not only due to the
higher rate of histamine synthesis in glomeruli, as we have
demonstrated, but also due to a lower rate of degradation.
However, since the distribution of SAM between glorneruli and
tubules is not known, the detailed role of additional factors that
determine histamine levels in glomeruli and tubules remains to
be determined.
The presence of an active diamine oxidase pathway specifi-
cally in glomeruli with little activity in the cortical tubular
preparation should be briefly considered. The enzyme histami-
nase is present in the kidney of various species, including the
rat [15, 16]. However, since the histamine inhibitor aminoguani-
dine had no effect on the catabolism of histamine in whole rat
kidney slices or renal homogenates in vitro, some investigators
concluded that this pathway does not play a role in histamine
catabolism in the rat kidney in vitro [26, 271. It is most likely
that such studies reflect primarily effects in tubules, and mask
the metabolic activity in glomeruli, which constitute a small
percentage of whole renal tissue. Imidazole acetic acid, the
major product of this pathway, is a chemoattractant for leuko-
cytes [15] and has recently been shown to inhibit histaminase
release from leukocytes [17] and to modulate complement-
induced leukocyte function [18]. These effects are specific for
imidazole acetic acid but not for other imidazole compounds
and have been demonstrated at very low concentrations
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Fig. 4. The effect of increasing concentrations of S-Adenosylmethionine
(SAM) on product formation in isolated glomeruli and tubules. Incuba-
tions were carried out in the presence of 5 x 106M '4C-histamine for
120 mm. Labelled histamine and metabolites were separated on thin
layer chromatography. Each point represents the mean SEM of four
determinations (two incubation samples aliquoted in duplicates).
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Fig. 6. Amounts of '4C-labelled imidazole acetic acid and its riboside
(IMAA + R) (upper panel) and '4C-labelled IVr-methylhistamine (Ni- -
MH) (lower panel) formed in glomeruli and tubules incubated with 5 x
106M '4C-histamine in the absence (open bars) and the presence
(hatched bars) of 104M S-Adenosylmethionine (SAM) for /20 mm.
Values are mean SEM of four experiments (each run in duplicate or
triplicate incubation samples). The asterisk denotes values in tubules
significantly different (P < 0.05 or better; unpaired t test) from
corresponding values in glomeruli.
Fig. 7. Changes in histamine levels in glomeruli (solid lines) and in
tubules (broken lines) after incubations in the absence or presence of
104M S-Adenosyl-me:hionine. The upper panel represents incubations
that contained 100 pmoles of nonlabelled histamine (0.5 x l06M);
lower panel represents incubations that contained 1,000 pmoles of
nonlabelled histamine (5 x 106M). Histamine levels in control tubes (0
incubation time) and tubes incubated for 120 mm were determined by
radioenzymatic assay. The asterisk denotes values (decrease in hista-
mine) significantly different (P < 0.05 or higher degree of significance;
paired t test) from corresponding levels in the absence of SAM.
(<l09M) that may be achieved in the kidney. It is conceivable
that this histamine product, in addition to histamine itself, may
modulate inflammatory responses initiated by either intrinsic
glomerular cells or in cells infiltrating the glomerulus in the
course of immune-mediated renal injury. Locally produced
IMAA may also regulate the rate of histamine destruction and
therefore its availability for cells possessing histamine
receptors.
The current observations that tubules more actively degrade
histamine than glomeruli, that histamine acting via an H2
receptor exerts a striking, specific stimulatory effect on glomer-
ular cyclic nucleotides production [12, 13], and that glomeruli
but not cortical tubules synthesize histamine [10, 11] suggest
that glomeruli are major sites of histamine synthesis and action
in the kidney while tubules are major sites of histamine degrada-
tion. Previous studies have shown that the availability of the
substrate-L-histidine and the activity of histidine decarboxyl-
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ase, key enzyme of histamine synthesis, may be an important
mechanism that regulates histamine levels in various tissues
including the kidney [11, 31, 32]. Our studies suggest that, in
addition, the activity of the histamine catabolizing enzymes and
the availability of their cofactors may play a major role in
determining the dynamics of histamine metabolism in various
anatomical sites in the kidney. The diamine oxidase inhibitor
aminoguanidine and the histamine methyltransferase inhibitor
amodiaquine are active not only in vitro but also in vivo [14—
16]. In vivo modulation of SAM in the kidney can be achieved
by the administration of methionine [28]. Therefore, as demon-
strated in other tissues, it should be feasible to modulate the
renal and specifically the glomerular content of histamine by
either altering its substrate availability, or by changing the
activity of its synthesizing or degrading enzymes and their
cofactors [3 1—32]. Such maneuvers may provide a valuable tool
for exploring the actions of histamine in physiological or
pathological states in the kidney.
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